WA
RNAC icon

Wasatch Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Wasatch Advisors’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-68,992
Closed -$5.13M – 262
2020
Q3 		$5.13M Sell
68,992
-12,343
-15% -$946K 0.03% 201
2020
Q2 		$6.93M Sell
81,335
-26,118
-24% -$2.37M 0.05% 179
2020
Q1 		$7.77M Sell
107,453
-39,775
-27% -$3.84M 0.08% 145
2019
Q4 		$10.1M Buy
147,228
+76,629
+109% +$3.7M 0.08% 156
2019
Q3 		$3.71M Sell
70,599
-14,435
-17% -$767K 0.04% 213
2019
Q2 		$4.57M Sell
85,034
-12,423
-13% -$847K 0.04% 189
2019
Q1 		$6.93M Buy
97,457
+93,774
+2,546% +$5.94M 0.08% 143
2018
Q4 		$294K Sell
3,683
-4,041
-52% -$922K ﹤0.01% 226
2018
Q3 		$3.6M Sell
7,724
-130
-2% -$52.2K 0.04% 197
2018
Q2 		$3.12M Buy
7,854
+660
+9% +$234K 0.04% 193
2018
Q1 		$2.2M Sell
7,194
-1,027
-12% -$293K 0.03% 215
2017
Q4 		$2.42M Buy
8,221
+4,124
+101% +$1.8M 0.03% 210
2017
Q3 		$2.24M Sell
4,097
-49
-1% -$26.1K 0.03% 231
2017
Q2 		$2.47M Buy
4,146
+1,656
+67% +$731K 0.03% 225
2017
Q1 		$1.07M Sell
2,490
-2
-0.1% -$842 0.02% 302
2016
Q4 		$1.28M Hold
2,492
– – 0.02% 299
2016
Q3 		$1.07M Sell
2,492
-43
-2% -$16.8K 0.02% 303
2016
Q2 		$1.06M Buy
+2,535
New +$1.06M 0.02% 314

Other funds holding RNAC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wasatch Advisors's RNAC Position: Q4 2020 in Review

Wasatch Advisors sold out of Cartesian Therapeutics (RNAC) in Q4 2020, closing a stake of 68,992 shares — an estimated $5.13M sold.

Wasatch Advisors first reported a position in RNAC in Q2 2016 and held it in 18 quarters. The position peaked at $10.1M in Q4 2019. 95 funds tracked by Wall St. Rank hold RNAC as of Q4 2020.

  • Wasatch Advisors reported no remaining Cartesian Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Wasatch Advisors sold 68,992 Cartesian Therapeutics shares in Q4 2020, an estimated $5.13M.
  • Wasatch Advisors first reported a position in Cartesian Therapeutics in Q2 2016 and held it in 18 quarters.
  • Wasatch Advisors's Cartesian Therapeutics position peaked at $10.1M in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2020.

Based on Wasatch Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.